Oct. 2 at 7:03 PM
Don't be fooled by the new name bots, shills, & bad actors here... or the clowns selling the deep red 'exo trifecta'.
$MYO has a near-zero path to profitability.
Nearly two years after CMS approval - and still a
$30M shortfall! - in a year they practically promised a profit.
But perhaps the biggest red flag? The actual *users* of this dead weight... read up, they mostly hate the product. Cumbersome AF. One new user cites needing shoulder surgery after usage. Old tech. Dead tech.
So rest assured: A dilution is coming. A reverse split, likely coming. And now it's just a matter of time whether it's the product, or its peddlers, that die first.